Cemented Plus Abutment
Unidental Co., Ltd. · Decision date Sep 23, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-09-23 for the Cemented Plus Abutment, submitted by Unidental Co., Ltd. of Gwangmyeong-Si, Republic of Korea, under 510(k) number K262207. The device is classified as an endosseous dental implant abutment (product code NHA, regulation 872.3630) in the Dental specialty and review panel. The application was received on 06/30/2026 and is listed as a traditional 510(k) not reviewed by a third party.
SESE denotes 510(k) clearance to market, not premarket approval. The record identifies the reviewed item as the Cemented Plus Abutment and describes it as an endosseous dental implant abutment, Class II; the available excerpts do not specify individual components, materials, or any change relative to a predicate device. The public summary field is empty, so the basis for the equivalence determination, including performance data and any clinical information, remains unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262207
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Unidental Co., Ltd.
- Product code
- NHA
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Abutment, Implant, Dental, Endosseous.
- Applicant
- Unidental Co., Ltd.
- Product code
- NHA
- FDA device class
- 2
FDA decision timeline
K262207 received
Application receipt date recorded by FDA.
K262207 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NHA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Elos Accurate Hybrid BaseK261327 | Elos Medtech Pinol A/S | 510(k) clearance | Sep 30, 2026 | FDA |
BellaTek BarsK260940 | ZimVie US Corp, LLC | 510(k) clearance | Sep 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Unidental Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Gwangmyeong-Si
Sources and methodology
- Original FDA record: K262207
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
